SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-116648
Filing Date
2016-08-04
Accepted
2016-08-04 16:53:19
Documents
49
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v444808_10q.htm 10-Q 356095
2 EXHIBIT 31.1 v444808_ex31-1.htm EX-31.1 10265
3 EXHIBIT 31.2 v444808_ex31-2.htm EX-31.2 10108
4 EXHIBIT 32.1 v444808_ex32-1.htm EX-32.1 5021
5 EXHIBIT 32.2 v444808_ex32-2.htm EX-32.2 4968
  Complete submission text file 0001144204-16-116648.txt   3499216

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20160630.xml EX-101.INS 812685
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20160630.xsd EX-101.SCH 33235
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20160630_cal.xml EX-101.CAL 38624
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20160630_def.xml EX-101.DEF 199688
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20160630_lab.xml EX-101.LAB 245241
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20160630_pre.xml EX-101.PRE 228782
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 161808170
SIC: 2834 Pharmaceutical Preparations